Using patient data to predict health events in scleroderma
Harnessing multivariate patient- and population-level disease trajectories to predict major clinical events in scleroderma
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-11042211
This study is looking at how scleroderma affects people in different ways over time, so we can find patterns that help doctors give better, personalized care to patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11042211 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how scleroderma, a complex autoimmune disease, affects patients differently over time. By analyzing detailed clinical data, the study aims to identify patterns in disease progression and the occurrence of major health events. The approach involves capturing individual patient trajectories and using advanced modeling techniques to predict outcomes based on shared characteristics among patients. This could help tailor treatments and improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with scleroderma who are experiencing varying symptoms and disease progression.
Not a fit: Patients with scleroderma who have stable disease and do not exhibit significant variability in their symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment plans for scleroderma patients, improving their health outcomes.
How similar studies have performed: Previous research has shown promise in using patient data to improve understanding of autoimmune diseases, indicating that this approach could be effective.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SHAH, AMI AALOK — JOHNS HOPKINS UNIVERSITY
- Study coordinator: SHAH, AMI AALOK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: anti-cancer